Skip to main content

1 Result(s)

within Dana Ilic Bogojevic Remove this filter

and

  1. No Access

    Article

    A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe

    Lipegfilgrastim (Lonquex, Teva Pharma B.V.) is approved for reduction in neutropenia duration and febrile neutropenia incidence. In the framework of lipegfilgrastim regulatory approval in the EU, the Health Au...

    Sigal Kaplan, Dana Ilic Bogojevic, Carolyn Rainville… in Supportive Care in Cancer (2022)